Clinical Trial Update: Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study [Phase 1, Phase 2]

View source ↗

Summary

An early-phase trial evaluating the safety, tolerability, and bioactivity of tocilizumab in adults with noninfectious uveitis (STOP-UVEITIS). The study includes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Uveitis
• Noninfectious Uveitis
• Panuveitis
• Posterior Uveitis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University of Nebraska | Conditions: Intermediate Uveitis, Posterior Uveitis | Phase 1, Phase 2 | Status: UNKNOWN